The most advanced imaging tools available to date were used recently at OU Health to help identify and confirm staging in men at risk for spread of cancer and progression of prostate cancer after treatment.
The OU Health Board of Directors on Feb. 4 announced Richard Lofgren, MD, MPH, FACP, as CEO of OU Health, Oklahoma’s only integrated, comprehensive academic health system.
Drug developed to suppress cancerous tumors also has ability to lower blood sugar levels that were elevated due to obesity and Type 2 diabetes.